Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...
As the need to draw awareness to cervical, ovarian, uterine/endometrial, vaginal, and vulvar cancer becomes more evident, ...
Mutations on BRCA1 and BRCA2, two genes known to also increase the risk for breast, prostate and other kinds of cancer, are ...
HAMPTON TOWNSHIP, Pa. (KDKA) -- The National Ovarian Cancer Coalition Great Lakes chapter held its biggest fundraiser of the ...
Researchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and ...
Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...
Researchers have identified thousands of genetic variants in a gene that could raise an individual's risk of ovarian and ...
New reserach has identified particular genetic mutations that elevate the risk of breast and ovarian cancers, aiding in ...
Dr. Diego Aviles with UT Physicians says symptoms of ovarian cancer typically include bloating, pain in the stomach or pelvis ...